South Korea
· Delayed Price · Currency is KRW Bio Solution Co.,Ltd. Statistics
Total Valuation
Bio Solution Co.,Ltd. has a market cap or net worth of KRW 117.87 billion.
| Market Cap | 117.87B |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Bio Solution Co.,Ltd. has 8.02 million shares outstanding.
| Shares Outstanding | 8.02M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 18.92% |
| Owned by Institutions (%) | 0.25% |
| Float | 6.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.15 |
| PB Ratio | 2.51 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.04, with a Debt / Equity ratio of 0.03.
| Current Ratio | 16.04 |
| Quick Ratio | 15.34 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.75 |
| Interest Coverage | -59.17 |
Financial Efficiency
Return on equity (ROE) is -2.71% and return on invested capital (ROIC) is -3.62%.
| Return on Equity (ROE) | -2.71% |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | -3.62% |
| Revenue Per Employee | 116.55M |
| Profits Per Employee | -18.07M |
| Employee Count | 71 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.68% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +5.68% |
| 50-Day Moving Average | 13,854.80 |
| 200-Day Moving Average | 16,457.60 |
| Relative Strength Index (RSI) | 61.14 |
| Average Volume (20 Days) | 7,943 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bio Solution Co.,Ltd. had revenue of KRW 8.27 billion and -1.28 billion in losses. Loss per share was -161.07.
| Revenue | 8.27B |
| Gross Profit | 4.70B |
| Operating Income | -2.80B |
| Pretax Income | -1.28B |
| Net Income | -1.28B |
| EBITDA | -964.75M |
| EBIT | -2.80B |
| Loss Per Share | -161.07 |
Balance Sheet
The company has 36.42 billion in cash and 1.24 billion in debt, giving a net cash position of 35.18 billion or 4,384.70 per share.
| Cash & Cash Equivalents | 36.42B |
| Total Debt | 1.24B |
| Net Cash | 35.18B |
| Net Cash Per Share | 4,384.70 |
| Equity (Book Value) | 46.62B |
| Book Value Per Share | 5,848.18 |
| Working Capital | 38.67B |
Cash Flow
In the last 12 months, operating cash flow was -912.77 million and capital expenditures -747.23 million, giving a free cash flow of -1.66 billion.
| Operating Cash Flow | -912.77M |
| Capital Expenditures | -747.23M |
| Free Cash Flow | -1.66B |
| FCF Per Share | -206.89 |
Margins
Gross margin is 56.82%, with operating and profit margins of -33.80% and -15.50%.
| Gross Margin | 56.82% |
| Operating Margin | -33.80% |
| Pretax Margin | -15.50% |
| Profit Margin | -15.50% |
| EBITDA Margin | -11.66% |
| EBIT Margin | -33.80% |
| FCF Margin | -20.06% |
Dividends & Yields
Bio Solution Co.,Ltd. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.40% |
| Shareholder Yield | -1.40% |
| Earnings Yield | -1.10% |
| FCF Yield | -1.41% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bio Solution Co.,Ltd. has an Altman Z-Score of 36.49.
| Altman Z-Score | 36.49 |
| Piotroski F-Score | n/a |